Presentations and Articles

Note: Some of the documents linked to this page are in Portable Document Format (PDF), and require the Adobe® Acrobat Reader for viewing. If you do not have the Acrobat Reader, visit https://get.adobe.com/reader/ to download.

NIH Technology Transfer Training This training is mandatory for the following groups at NIH: (NOTE: This link will only work from within NIH firewall) All Principal Investigators (Senior Investigators, Investigators, Adjunct Investigators, Senior Scientists/Clinicians, and Assistant Clinical Investigators ) Fellows Graduate Students Staff Scientists/Staff Clinicians

Intellectual Property and Technology Transfer Bruce Goldstein In: JI Gallin, FP Ognibene, LL Johnson, eds. Principles and Practice of Clinical Research (Fourth Edition). (Academic Press/Elsevier Inc.) 2017:447–529.
A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug Development Berna Uygur, Josh Duberman, and Steven M. Ferguson J Commer Biotechnol. 2017 May;23(2):75-81.
Beyond Hybrid Licenses—Strategies for Post Patent Expiration Payments in the United States Patrick Gattari, Steven Ferguson, David Crichton, and Bryan Helwig les Nouvelles. 2017 Mar;52(1):31-6.
Licensing the Technology: Biotechnology Commercialization Strategies Using University and Federal Labs (2nd Edition) Steven M. Ferguson and Uma S. Kaundinya In: Craig Shimasaki, ed. Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies. (Elsevier Inc.) 2020:199-222.
NIH Inventions Translate into Drugs and Biologics with High Public Health Impact Sabarni K. Chatterjee and Mark L. Rohrbaugh Nat Biotechnol. 2014 Jan 9;32(1):52-8.
If The Sky Were The Limit, What Would You Do In Technology Transfer? Gary Keller, Fizie Haleem, Steven Ferguson, Al Jordan, and Cheryl Cejka les Nouvelles. 2013 Mar;47(1):66-70.
Partnering with the NIH: Now part of the "Value Proposition" for start-ups Steven M. Ferguson J Commer Biotechnol. 2012 Apr 1;18(2):60-67.
License Compliance Issues for Biopharmaceuticals: Special Challenges for Negotiations between Companies and Non-Profit Research Institutions Todd A. Ponzio, Hans Feindt, and Steven M. Ferguson les Nouvelles, 2011 Sep;46(3):216-25.
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines Ashley J. Stevens, Jonathan J. Jensen, Katrine Wyller, Patrick C. Kilgore, Sabarni Chatterjee, and Mark L. Rohrbaugh N Engl J Med. 2011 Feb 10;364(6):535-41.

Presentations & Articles Archive